COLTUXIMAB RAVTANSINE

UNII: MRS84YT9L2
Preferred Substance Name: COLTUXIMAB RAVTANSINE

1269764-99-9
ANTI-CD19 HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO DM4
COLTUXIMAB RAVTANSINE [INN]
COLTUXIMAB RAVTANSINE [WHO-DD]
IMMUNOGLOBULIN G1 (HUMAN-MOUSE MONOCLONAL HUB4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HUB4 LIGHT CHAIN, DIMER, TETRAAMIDE WITH N2'-(4-((3-CARBOXYPROPYL)DITHIO)-4-METHYL-1-OXOPENTYL)-N2'-DEACETYLMAYTANSINE
SAR3419
SAR-3419

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

COLTUXIMAB RAVTANSINE

Synonyms and Mappings

Resources

Note